The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial
Negar Iranpour(Roozbeh Hospital), Shahin Akhondzadeh(Roozbeh Hospital), Sophia Esalatmanesh(Roozbeh Hospital), Bahman Salehi(Arak University of Medical Sciences), Amirhossein Goguol(Roozbeh Hospital), Payam Mohammadinejad(Roozbeh Hospital), Habibeh Yekehtaz(Arak University of Medical Sciences), Mehdi Farokhnia(National Institute on Drug Abuse), Atefeh Zandifar(Roozbeh Hospital), Atefeh Zeinoddini(Massachusetts General Hospital), Atefeh Zeionoddini(Roozbeh Hospital)
Cited by 57
Related Papers
A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence–Powered Ultrasound for Improving Clinical Workflow
|Journal of the American College of Radiology|2019|319
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151